Counterfeit Alli
FDA Warns Consumers about
Counterfeit Alli.
The counterfeit products contain controlled substance sibutramine.
The U.S. Food and Drug Administration is today warning consumers about a counterfeit and potentially harmful version of
Alli 60 mg capsules (120 count refill kit).
Preliminary laboratory tests conducted by GlaxoSmithKline (GSK)—the maker of the FDA approved over-the-counter weight-loss product— revealed that the counterfeit version did not contain
orlistat, the active ingredient in its product. Instead, the counterfeit product contained the controlled substance sibutramine. Sibutramine is a drug that should not be used in certain patient populations or without physician oversight. Sibutramine can also interact in a harmful way with other medications the consumer may be taking.